Calculus Vct Share Discussion Threads

[spreadit] 23/2/2002 00:32

you say there record is dissapointing,i am glad i have held clc over the past few years,dont forget we are in a bear market(past 2 years approx) i think clc have held up pretty well compared to a lot of companys we could mention ,i dont think clc will let us down in the long term we have just got to be patient -someting we have all forgot to do when investing (or did i mean short term punting) DYOR

[orange1] 22/2/2002 13:44

Well, I have held since flotation and whatever way you look at it over that period of time they have been a disappointment: flotation price 125p, current price: 37,5p. Turnover in 1993: 2.6m, turnover in 2001: 2.1m.

That is not to say though that I am not optimistic for the future - hence my post.

Apart from the announcement, another bullish sign was the purchase in November of last year of 65 000 shares by director Howard Kitchner, his first since the company was floated.

Had to laugh though - he bought them for his 15 year old son, Andrew. Picture the scene in the Kitchner household: it is son's 15th birthday. Son is hoping for a surf board or a moped or an electronic toy of some sort. Instead Dad hands him a share certificate: "Here you are son, a solid investment, an investment for the future. When you are 18 this investment will be large enough to buy you a surf board factory and an island in the sun."

"Yeah, Dad, right", says young Andrew and he slopes off dejectedly muttering "shares, I don't bloody believe it!" as he goes.

[a.fewbob] 20/2/2002 12:02

You could be right but having disapointed for so looooong i think clc have about as much credability as new labour.

[orange1] 20/2/2002 07:48

As you say their record is very disappointing. My point is that finally, not least because of their new product, things might finally be about to get considerably better. The recent contract wins are in my view evidence of that.

[orange1] 19/2/2002 22:08

Clinical Computing (CCL) is the leading provider of clinical computer information systems and services in the renal dyalasis industry in North America and the UK.
The company was founded in 1979. From 1998 CCL has sold its suite of products under the generic label PROTON. The company was admitted to the Official List in 1994.
Since 1995 sales have declined in the UK but grown in the USA. Sales generally have tailed off since 1997 (maintenance figures have been on the up though) as the following table shows (figures are in 000s):


1993 1994 1995 1996 1997 1998 1999 2000 2001

1980 811 1200 746 1400 830 748 584 ? licence sales

411 507 684 703 949 1500 1600 1430 ? maintenance

43 86 123 238 321 251 433 143 ? services

137 13 108 152 260 220 205 17 ? hardware sales

58 54 64 140 87 96 99 54 ? other

2600 1470 2190 1980 3020 3040 3100 2300 2100 total

Since 1998 CCL have been developing a new set of clinical information products called Clinical Vision not only for the renal dyalasis market but for other clinical markets as well. This system is web enabled and integrates the point of care hand held device Pocket CV allowing the clinician to have the pertinent data available at the patient’s bedside. Sales of the old PROTON products have tailed off in anticipation of the launch of Clinical Vision.

The recent announcement by CCL of contract gains in the USA, amounting to $US728,000 (£515,000), from its new Clinical Vision product for the renal dialysis and transplant markets is significant because:

1. it seems to confirm the quality of the product (note the mixture of existing and new clients)

2. the sales already booked for 2002 most probably exceed those for 2001 and nearly equal those for 2000

3. in the 2000 Annual Report CCL talked of Clinical Vision proving to be “a source of substantial upgrade business” (quite irrespective of new business). Given that maintenance figures currently run at some £ 1.4 m, this implies that the potential for upgrade business indeed runs into many millions.

It is fair to say that since listing in 1994, CCL have been perennial underperformers. The recent announcement could however herald a new dawn for CCL. Their brokers have in the past without fail overestimated the prospects of CCL. Last year they were predicting a pretax profit of 200k for 2001 (there will in fact be a loss). For 2002 they were
predicting pre tax profits of £ 1.4 m and EPS of 5.6p on a nil tax rate. The corresponding PE is 6.7. This time given that sales of £ 515 k are already in the bag I have a feeling that they could well finally be right. If so the shares have some way to travel.

[fredd] 18/2/2002 00:45

Have bought 4 lots over the years,never had any problems above nms. Never tried an online transaction though.

[spreadit] 18/2/2002 00:42

i have held this share for a few years have had no problems buying or selling above nms of 1000 but i have found that i have to phone my broker for the deal i want above 1000 nms, hope this helps

[balto] 17/2/2002 11:12

I don't know much about this company.
I came across the chart and it seems to me it's doing an upside breakout.
My concern is with the NMS of only 1000 shares.
Did (anybody) had any problem in the past buying and selling above this limit???
Thank you

[spreadit] 15/2/2002 22:49

nice to see some good news anyone have any views on clc

[fredd] 15/2/2002 10:19

Contract wins:

RNS Number:5155R
Clinical Computing PLC
15 February 2002



For Immediate Release 15 February 2002



CLINICAL COMPUTING PLC: CONTRACT GAINS FOR
CLINICAL VISION PRODUCT AND DATE FOR NEXT FINAL RESULTS

Clinical Computing Plc ("CCL"), which produces leading clinical software
systems, announces that it will report its final results for the year ended 31
December 2001, on Monday, 25th March 2002. At that time, it will expect to
report turnover for that year in the order of £2.1m.


CCL also announces the following contract gains in the United States, amounting
to $US728,000 (£515,000), from its new Clinical Vision product for the renal
dialysis and transplant markets. These contracts will be recognized in CCL's
current financial year ending 31 December 2002.


The contract gains are from (full text):

[fredd] 01/2/2002 13:15

Here we go again - up 14.8%

[jasey3] 21/10/2001 05:37

CHECKOUT EINSTEIN TV ,, EPIC EIC ,THIS BABYS FLYING

[nidal] 24/1/2001 22:51

Bizarre, that's all I can say. I don't know of any news on this.

[colsmith] 24/1/2001 15:31

Share has been in the pits for months falling to 22p. Company appears to have a range of software products that are selling however, the rise of 27% today seems to be without any news. Anyone aware of news or is it just the momentum buyers.

[saxon] 09/3/2000 22:08

Have a look at FT.Com. Click on "Company View". Scroll down underneath the chart and click on "Analyst Estimates" for Clinical Computing.

Looking at the projected profits - looks good to at least 200p very rapidly!

[swordfish] 09/3/2000 19:57

Interested in a virtually debt free company with an estimated eps growth of 300% this year? Then do some research into Clinical Computing.

Being a Medisys fan I was immediately attracted to this company - same area of business: medical (software and support), predominately in the USA. They've just completed development of their disease management system and are jointly marketing it with Roche UK. Lots of other goodies also currently being marketed.

Having got in at 72p two days ago I'm stoked by todays rise but I think there's a lot more to be had.

Any chartists out there with views on the upside?

[swordfish] 06/3/2000 23:22

gemstone

Just been doing some research into this company and came across your thread.

Did you ever get any more info from them on new products etc? I tried the link but the site does appear to be a little out of date.

Thanks for such a detailed post.

s

[gemstone] 25/1/2000 18:51

Below is a small extract from Clinical Computing's web site . Lots more info their well worth a look for more detailed info on their six main packages although various pages are still under construction. I spoke to the company today and they are mailing me more info with details on future new products they are working on and improvements & upgrades to existing products. I will post more information when I get it but I remain very optimistic about the future of this company. They have excellent products and offer excellent service. Perhaps now that the internet is shrinking the world their next product will even allow hospitals to share data this would be of great advantage to single facility organizations. Price today 62/66 unchanged after a rise yesterday Clinical Computing is an international organization with bases in USA, UK & Australasia focused on providing superior information systems and services, which promote continuous quality of care improvement to their clients and their client's patients. They are a provider of enterprise-wide clinical systems with application areas in: renal, transplantation, oncology and disease management. The parent company is a UK public corporation traded on the London Stock Exchange. Clients range from the largest provider of dialysis in the US to single facility organizations. As the market share leader in the renal segment they offer a number of key product functional advantages. Their size and resulting financial strength allow them to focus on customer support while continuing to invest in research and development. Their staff comprises of a wide variety of professionals with extensive experience in nursing, medical records, system management, administration and application programming. The care and treatment of patients generates substantial quantities of data. This data has generally been paper based. The benefits of computerizing are now widely recognized. Clinical Computing is one of a very few companies to have succeeded in developing electronic patient record systems that balance administrative, medical audit, research and clinical requirements. As Clinical Computing has grown, both internally and through acquisition, they have been able to devote additional resource to building the service content of their business while still maintaining an intensive product development schedule. Clinical Computing's first general purpose system was sold in 1980 as the 'Clinical Data System', and was initially used primarily in renal and diabetic care. The first sale to the US market was in 1984, today over 1,300 dialysis centres now use PROTON. The products are scaleable and have an open architecture. This allows the customer to chose a hardware platform to meet existing needs while also allowing a growth path as technology evolves. PROTON's system software is written in 'C', facilitating ease of portability. Product deliverables are built with a focus on all aspects of the clinical environment. This perspective allowed them to deliver a system to maximize the productivity of all including but not limited to the doctor, technician, nurse and administrator. The application can be installed in networked PC's and UNIX based servers, and can be expanded to additional workstations or terminals as required. These applications can be linked to numerous other systems and can be interconnected with laboratory computers for the automatic request and collection of pathology data, and with case-mix patient administration computers and hospital information systems for the automatic exchange of clinical and administrative data. As well as presenting clinical data in an efficient and user-friendly manner, these applications facilitate the interpretation and analysis of that data to assist in monitoring the progress of patients, so improving the quality of patient care and generating the most useful data for management and administrative functions.